Target identification and validation using AI for literature-based insights: Causaly & Pierre Fabre

Causaly and Pierre Fabre co-hosted a joint webinar on the 28th of October, addressing how pharmaceutical companies, in the context of Translational Medicine, combine Natural Language Processing and other AI technologies with expert judgement to investigate and select promising therapeutic targets.

Written by
Yiannis Kiachopoulos
  • Categories
  • Target Selection
Receive the latest newsletter directly to your inbox

Causaly and Pierre Fabre joint webinar

Causaly AI was proven to save 80% of their research time.

More on Target Selection